Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cellophil™ is a platform of novel polymers based on amino-acid groups. The platform polymers show superior biocompatibility and can be loaded with drugs for controlled release. More
Biotechnology Product for Wound Healing More
Ophthalmologic Surgery More
Related Reports
Market Research Reports provided by reports.iptechex.com
Apr 2009 - 42 pages - $2,000
Jan 2011 - 78 pages - $3,500
Mar 2011 - 30 pages - $340
Nov 2010 - 11 pages - $99
May 2010 - 8 pages - $500
Dec 2008 - 46 pages - $2,000
Jun 2010 - 130 pages - $2,500
Jul 2009 - 124 pages - $3,500
Apr 2010 - 6 pages - $500
Mar 2010 - 145 pages - $1,500
Your selection
Browse By
- Industry sector
- Therapeutic device
- Therapeutic medical equipment
- Vision Care
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us